Home › Drug Codes › J Codes › J1413 · ELEVIDYS
Updated October 1st, 2026

ELEVIDYS J Code: J1413

Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
$3,301,546.667
/ HCPCS billing unit · APC 0714
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
61
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
HCPCS Added Date January 1, 2024
Manufacturer Sarepta Therapeutics
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Kit

About ELEVIDYS

Elevidys is a medication aligned to the HCPCS J Code: J1413 for billing, pricing, and reimbursement purposes in the United States. This Genetic Disorder medication is administered via the intravenous route and manufactured by Sarepta Therapeutics.

Manufacturers, reach out to us to add more information.

NDC Code Information

61 NDC packages are crosswalked to J1413. Package detail is available to logged-in subscribers.

Login to view 61 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ELEVIDYS Pricing & Reimbursement

J1413 Private Payer Reimbursement
$8,012.50 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

ELEVIDYS CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

ELEVIDYS Medically Unlikely Edits (MUE)

The most billing units of J1413 Medicare will pay for one patient in one day, as published by CMS. 1 unit = per therapeutic dose.

Practitioner Office & Hospital Outpatient
1 unit / day
Same limit in both settings

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

ELEVIDYS Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Duchenne muscular dystrophy

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Elevidys billing and coding guide?
Billing and coding information for ELEVIDYS can be found through Sarepta Therapeutics. Visit Here →
Are there any available Elevidys patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for ELEVIDYS.
Where can I find Elevidys prescribing information?
Our team is still working to identify a prescribing information source for ELEVIDYS
Where can I find Elevidys side effect information?
Our team has not yet identified a source of side effects information for ELEVIDYS. Please check back in a few weeks.
Does billing ELEVIDYS require JZ/JW wastage modifiers?
CMS does not include ELEVIDYS (J1413) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1413. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.